NEW ORLEANS – Cognitive behavioral therapy should be the first-line therapy for insomnia in seniors, but many clinicians are unaware of its benefits, experts say.
The prevalence of insomnia in older adults is estimated to be 20% to 40%, and medication is frequently the first treatment choice, a less than ideal approach, said Tampi. Dix noted that medications approved for insomnia by the US Food and Drug Administration, including melatonin receptor agonists, heterocyclics, and dual orexin receptor antagonists , can play an important role in the short-term management of insomnia, but their long-term effects are unknown.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: